Compare key investment metrics of 204840 and 현대약품 in real time. Both stocks belong to the 피임약 관련주 sector. View PER (Price-to-Earnings Ratio), PBR (Price-to-Book Ratio), dividend yield, market capitalization, and 52-week high/low side by side, with automatic highlighting of the leading stock for each metric.
Comparison at a Glance
- By market capitalization, 현대약품 is larger — ₩160B vs 204840's ₩64B. Larger companies tend to be less volatile, while smaller ones may offer more growth headroom.
- 204840's current price of 823원 sits at about 8% of its 52-week range (778원–1,330원).
- 현대약품's current price of 5,000원 sits at about 12% of its 52-week range (3,450원–15,960원).
- This comparison is for reference only, based on publicly available market data, and does not constitute investment advice.
| Metric | 204840 | 현대약품 |
|---|---|---|
| Price | 823원 | 5,000원 |
| PER | - | 40.65배 |
| PBR | 3.23배 | 1.03배 |
| Dividend Yield | - | 0.6% |
| Market Cap | ₩64B | ₩160B |
| 52-Week High | 1,330원 | 15,960원 |
| 52-Week Low | 778원 | 3,450원 |
As of 2026-07-06 · Source: KRX (Naver Finance) public data
Frequently Asked Questions
Which has a lower PER, 204840 or 현대약품?
PER (Price-to-Earnings Ratio) divides a stock's price by its earnings per share. A lower PER may suggest the stock is undervalued relative to its earnings. Since PER changes with each earnings report, check the real-time comparison table on this page for the latest 204840 and 현대약품 PER values.
What is the dividend yield difference between 204840 and 현대약품?
Dividend yield measures annual dividends as a percentage of the stock price. A higher yield means more cash income per dollar invested. The dividend yields of 204840 and 현대약품 fluctuate with dividend policy changes and stock price movements — check this page's live data for the most current comparison.
How to compare 204840 and 현대약품?
PFlow's stock comparison page lets you compare key investment metrics side by side — PER, PBR, dividend yield, market cap, and 52-week high/low. Each metric automatically highlights which stock has the advantage. For deeper analysis, visit each stock's dedicated detail page.